Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study is designed to check the effect of the use of the ear popper device on serous otitis media in children and on the conductive hearing loss accompanying the otitis. It is intended that 30 children aged 3-18 years will participate in the study. The inclusion criteria are : clinical serous otitis media for a duration of more then 3 months, a conductive hearing loss of at least 15 decibels air bone gap and tympanometry type B or C. The children will use the ear popper for 7 weeks. They will undergo otologic examination, audiometry and tympanometry at the beginning ao the trial, at 7 weeks and at 3 months from the beginning of the trial. The otologic findings and the audiometry and tympanometry results before and after the trial will be compared. We will try to determine whether the use of the ear popper in the test group will improve the conductive hearing loss and prevent the need for tympanostomy tube insertion.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Ear Popper | Device |
| Measure | Description | Time Frame |
|---|---|---|
| Audiometry and tympanometry test results at at 7 weeks and 3 months from beginning of use of the ear popper. | ||
| Otoscopic findings at at 7 weeks and 3 months from beginning of use of the ear popper. |
| Measure | Description | Time Frame |
|---|---|---|
| Hearing improvement at 7 weeks and 3 months from the beginning of the trial. | ||
| Rate of referrals for tympanostomy tube insertion at 3 months |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Yael Oestreicher, MD | Contact | 972-3-6974517 | dkyo@barak-online.net.il | |
| Ari DeRowe, MD | Contact | 972-3-6974517 |
| Name | Affiliation | Role |
|---|---|---|
| Yael Oestreicher, MD | Tel Aviv Medical Center | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| ENT Unit, Dana Children's Hospital, Tel-Aviv Medical Center | Recruiting | Tel Aviv | Israel |
Not provided
| ID | Term |
|---|---|
| D010033 | Otitis Media |
| D006314 | Hearing Loss, Conductive |
| D010031 | Otitis |
| ID | Term |
|---|---|
| D004427 | Ear Diseases |
| D010038 | Otorhinolaryngologic Diseases |
| D034381 | Hearing Loss |
| D006311 | Hearing Disorders |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| D012678 |
| Sensation Disorders |
| D009461 | Neurologic Manifestations |
| D009422 | Nervous System Diseases |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |